Skip to content

Author

J. Benítez-Fuentes

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Venous and arterial thromboembolic events associated with osimertinib in patients with lung cancer: a study by the thrombosis and cancer group of the spanish society of medical oncology (SEOM).

PURPOSE To determine the real-world clinical practice incidence and predictive factors of venous and arterial thromboembolic events (VTE/ATE) in lung cancer patients treated with osimertinib. METHODS/PATIENTS A multicenter retrospective study including 546 lung cancer patients who initiated treatment with osimertinib...

Manuel Sánchez Cánovas, Javier López Robles, C. Fernandez-Reino et al. · 0 citations
#small language model Open access Sep 2026

Baseline Gustave Roussy Immune Score and Survival in Extensive-Stage Small-Cell Lung Cancer Treated with First-Line Chemoimmunotherapy

Baseline Gustave Roussy Immune Score (GRIm) was the most consistent candidate prognostic marker in this real-world ES-SCLC cohort and was identified markedly shorter overall and progression-free survival.

David Sánchez García, Miguel Borregón-Rivilla, A. Moya-Martínez et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.